Slowing Aging of the Ovaries
August 13, 2026
Ovaries are one of the first organs to age, and their decline shapes women’s health decades later
Ovaries are one of the first organs to age, and their decline shapes women’s health decades later
Some of medicine’s smallest patients can present its biggest imaging challenges. An infant’s heart can be as small as a walnut, beating rapidly inside a body that will change dramatically as the child grows. Yet much of the equipment used in MRI comes in standard sizes better suited to adult bodies, and customized versions can cost thousands of dollars and take months or even years to manufacture.
Certification strengthens Koning’s global regulatory foundation as two new Vera Breast CT systems expand patient access in key U.S. markets
Viral reservoirs in a proxy animal model of HIV share features with immune-suppressive tumors
Tiny, near-invisible fragments of plastic shed from the products we use every day through sunlight and mechanical wear have been quietly working their way deep into the human body. Microplastics have already been found in the human brain, semen and even the placenta. A recent study investigated how these micro- and nanoplastics (MNPs) might move through the placenta and whether they affect a baby’s development.
Researchers have developed an implant that could deliver next-generation therapies for ovarian cancer precisely where they are needed while simultaneously monitoring how the disease responds.
The DeepHealth Breast Ultrasound system automates the detection, characterisation, and reporting of breast lesions.
GE HealthCare (Nasdaq:GEHC) announced today that it launched its new Invenia ABUS Prime and ABUS StreamVue platforms.
PITTSBURGH, July 29, 2026 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved Gwyn Lo™ (norelgestromin and ethinyl estradiol transdermal system). Gwyn Lo is a new combined hormonal contraceptive (CHC) patch with low-dose estrogen. The patch has demonstrated contraceptive efficacy for women of childbearing potential with a body mass index (BMI) below 30 kg/m² who are appropriate candidates for CHC. The Gwyn Lo dosage is norelgestromin 220 mcg/day and ethinyl estradiol 20 mcg/day.
Carea, the pregnancy and postnatal wellbeing app, has launched Carea Connect, a service that analyses a woman’s wellbeing data to identify when additional support may be beneficial and proactively connects her with the right maternal health expe